The Future of Medicine: Adult Stem Cells Cloned for First Time!

3dstemcellsBioprinting and the creation of artificial organs holds a great deal of promise for the field of medicine. By simply layering “bioinks” – which are are made up of stem cells – researchers have been able to form cell cultures and create artificial tissues, ranging from miniature kidneys and livers to cartilage and skin. The only drawback is that the base material in this operation – i.e. stem cells – has posed certain limitations, mainly in that scientists have been unable to clone them from specific patients.

 

However, thanks to a new research method, researchers have just succeeded in returning adult somatic (body) cells to a virgin stem cell state which can then be made into nearly any tissue. This breakthrough is likely reinvigorate efforts to use such cells to make patient-specific replacement tissues for degenerative diseases, for example to replace pancreatic cells in patients with type 1 diabetes. It’s a huge breakthrough in stem cell research in what has already been an exciting year. 

stem_cells2Last May, researchers from the Oregon Health & Science University in Beaverton perfected a process to therapeutically clone human embryos – thus producing cells that are genetically identical to a donor for the purpose of treating disease. In this case, the cells carried genomes taken from fetal cells and the cells of an eight-month-old baby. Then last month, two research groups announced that they had cloned stem cells from adult cells, independently and within a few days of each other.

The first announcement came on April 17th, when researchers at the CHA University in Seoul reported in Cell Stem Cell that they had cloned embryonic stem-cell (ES cell) lines made using nuclei from two healthy men, aged 35 and 75. On then on April 28th, researchers at the New York Stem Cell Foundation have taken body cells from a diabetic patient, transplanted the nucleus from those cells into a donor egg that has had its genetic material stripped, and allowed it to begin dividing.

stem_cells3In the latter case, the researchers reported that the new cells not only began dividing normally, but also began producing insulin naturally—a breakthrough that could eventually lead to a cure for the disease, in which patients are normally reliant on daily insulin injections. As Doctor Egli, leader of the New York Stem Cell Foundation team, said in a conference call with reporters:

We show for the first time that we are able to derive diploid, patient-specific stem cells and are able to induce these stem cells into becoming cells that produce and secrete insulin, showing that this technique should be useful for the development of cell-replacement therapies for diabetes.

The work was published in the journal Nature. Although not noted in the paper, Egli says that the cells work just as well as normally-functioning pancreas cells in non-diabetic humans.

bioprinted heartThe process behind both breakthroughs is known as somatic-cell nuclear transfer, which involves transplanting the “cloned” nucleus of a cell into an existing one that has had its nucleus removed. This is important because it is generally adults who stand to benefit the most from a fresh supply of cells to revitalize their ailing organs. And in addition to age-related treatment, this process offers options for the treatment of diseases that can cause damage to organs with time – in this case, Type 1 diabetes.

However, this day is still many years away, owing to numerous challenges posed by the process. At present, the technique is expensive, technically difficult, and ethical considerations are still an issue since it involves creating an embryo for the purpose of harvesting its cells lone. Obtaining human eggs also requires regulatory clearance to perform an invasive procedure on healthy young women, who are paid for their time and discomfort.

As a result, it is likely to be many more years before this process will becomes medically and commercially viable. That is to say, we won’t be seeing hospitals with their own bioprinting clinics where patients can simply go in, donate their cells, and swap out a diseased liver or damaged pancreas anytime soon. And as long as donated embryos are still a bottleneck, we can expect ethical and legal hurdles to remain in place as well.

Sources: extremetech.com, nature.com, motherboard.vice.com, cell.com

 

The Future is Here: Handheld 3-D Bioprinter

handheld_bioprinterSince it’s inception, bioprinting has offered medical science and astounding range of applications, with new being added every day. In just the past few years, researchers have found ways to create 3-D printed cartilage, replacement skin, and even miniature kidneys and livers using stem cells. And now, with this latest development, doctor’s may be able to “draw” replacement tissue as easily as they scrawl their signatures on a prescription pad.

It’s known as the BioPen, a handheld surgical device that works a little like a mini-3-D printer may soon be used to help repair damaged bones. Developed by Austrian researchers, the pen allows a surgeon to draw layers of stem cells directly at the site of an injury. Much like a a 3-D printer deposits plastic one layer at a time, the BioPen deposits gel in layers to create a 3-D structure.

BioPenAfter filling the damaged bone with the cells – mixed with a biodegradable seaweed extract to hold everything together- an ultraviolet light on the pen sets the gel in place. After the cells are in place, they multiply and eventually form functioning tissue. The device can also be used to apply growth factors to stimulate cell growth and other drugs (like cortisone) directly to where they are needed.

University of Wollongong professor Gordon Wallace, one of the researchers who is working on the project along with a team from the University of Melbourne, expressed the benefits of the device this way:

Biology works in 3-D. The ability to provide an appropriate structural environment for the stem cells enables more effective development into the appropriate tissue.

3dstemcellsIn the past, surgeons might have just injected stem cells to the desired area. But now, using the pen to build a small scaffold out of the gel, the cells can be better protected and more likely to survive. The researchers say it’s also easier to be precise with the pen in hand, and the whole process takes less time than surgeries would have in the past.

To further illustrate the uses and applications of additive manufacturing, the prototype itself was built in the researchers’ lab using a 3-D printer. According to Wallace, next-generation fabrication techniques not only made it possible to easily build the pen, but they also make it possible to quickly iterate new versions of the hardware.

bioprinted heartAnd while their partners at St. Vincent’s Hospital in Melbourne are working on optimizing the cell material, Wallace and his team of researchers will begin conducting animal trials with the BioPen, beginning later this year. If all goes well, the device could be undergoing human trials sometime in 2015, and available in hospitals in just a few years time.

And combined with other procedures that can generate replacement tissue (eyes, organs, skin), we will be looking at the age of biomedicine in full bloom!

Source: fastcoexist.com

The Future is Here: 3-D Printed Eye Cells

printed_eyecells3In the past few years, medical researchers have been able to replicate real, living tissues samples using 3-D printing technology – ranging from replacement ears and printed cartilage to miniature kidneys and even liver cells. Well now, thanks to a team of researchers from the University of Cambridge, eye cells have been added to that list.

Using a standard ink-jet printer to form layers of two types of cells,  the research team managed to print two types of central nervous system cells from the retinas of adult rats – ganglion cells (which transmit information from the eye to the brain), and glial cells (which provide protection and support for neurons). The resulting cells were able to grow normally and remain healthy in culture.

printed_eyecells2Ink-jet printing has been used to deposit cells before, but this is the first time cells from an adult animal’s central nervous system have been printed. The research team published its research in the IOP Publishing’s open-access journal Biofabrication and plans to extend this study to print other cells of the retina and light-sensitive photoreceptors.

In the report, Keith Martin and Barbara Lorber – the co-authors of the paper who work at the John van Geest Centre for Brain Repair at the University of Cambridge – explained the experiment in detail:

Our study has shown, for the first time, that cells derived from the mature central nervous system, the eye, can be printed using a piezoelectric inkjet printer. Although our results are preliminary and much more work is still required, the aim is to develop this technology for use in retinal repair in the future.

printed_eyecellsThis is especially good news for people with impaired visual acuity, or those who fear losing their sight, as it could lead to new therapies for retinal disorders such as blindness and macular degeneration. Naturally, more tests are needed before human trials can begin. But the research and its conclusions are quite reassuring that eye cells can not only be produced synthetically, but will remain healthy after they are produced.

Clara Eaglen, a spokesperson for the Royal National Institute of Blind People (RNIB), had this to say about the breakthrough:

The key to this research, once the technology has moved on, will be how much useful vision is restored. Even a small bit of sight can make a real difference, for some people it could be the difference between leaving the house on their own or not. It could help boost people’s confidence and in turn their independence.

printed_eyecells1Combined with bionic eyes that are now approved for distribution in the US, and stem cell treatments that have restores sight in mice, this could be the beginning of the end of blindness. And with all the strides being made in bioprinting and biofabrication, it could also be another step on the long road to replacement organs and print-on-demand body parts.

Sources: news.cnet.com, singularityhub.com, cam.ca.uk, bbc.co.uk